A 20-year perspective on the International Fanconi Anemia Registry (IFAR).

By D. Kutler, Bhuvanesh Singh, J. Satagopan, S. Batish, M. Berwick, P. Giampietro, H. Hanenberg, A. Auerbach. Blood, 2003

776 citations recorded by the source corpus.

Fanconi anemia (FA) is an autosomal recessive disorder characterized by cellular hypersensitivity to DNA cross-linking agents and cancer predisposition. Recent evidence for the interactions of ataxia-telangiectasia mutated protein ATM and breast cancer susceptibility proteins BRCA1 and BRCA2 (identified as FANCD1) with other known FA proteins suggests that FA proteins have a significant role in DNA repair/recombination and cell cycle control. The International Fanconi Anemia Registry (IFAR), a prospectively collected database of FA patients, allows us the unique opportunity to analyze the natural history of this rare, clinically heterogeneous disorder in a large number of patients. Of the 754 subjects in this study, 601 (80%) experienced the onset of bone marrow failure (BMF), and 173 (23%) had a total of 199 neoplasms. Of these neoplasms, 120 (60%) were hematologic and 79 (40%) were nonhematologic. The risk of developing BMF and hematologic and nonhematologic neoplasms increased with advancing age with a 90%, 33%, and 28% cumulative incidence, respectively, by 40 years of age. Univariate analysis revealed a significantly earlier onset of BMF and poorer survival for complementation group C compared with groups A and G; however, there was no significant difference in the time to hematologic or nonhematologic neoplasm development between these groups. Multivariate analysis of overall survival time shows that FANCC mutations (P =.007) and hematopoietic stem cell transplantation (P = <.0001) define a poor-risk subgroup. The results of this study of patients registered in the IFAR over a 20-year period provide information that will enable better prediction of outcome and aid clinicians with decisions regarding major therapeutic modalities.

Subfields: Cancer Research, Genetics, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/8363cbb267281a535706546701a9ef9482962160

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

O. Levran
J. Satagopan
D. Kutler
Raffaella Diotti
L. Ben-Porat
M. Berwick
Kanan D. Pujara
S. Batish

Citations in the corpus

A note on competing risks in survival data analysis (2004, background): “A note on competing risks in survival data analysis JM Satagopan*,1, L Ben-Porat1, M Berwick2, M Robson3, D Kutler4 and AD Auerbach5 1Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York 10021, USA; 2Division of Epidemiology, Cancer Research Facility, Univer”
Spectrum of sequence variations in the FANCA gene: An International Fanconi Anemia Registry (IFAR) study (2003, background): “Mutations in the gene for complementation group FA-A (FANCA, MIM# 607139), the most common complementation group, account for approximately 65% of all cases [Faivre et al., 2000, Kutler et al., 2003].”